2. Metabolic Enzyme/Protease NF-κB Immunology/Inflammation Apoptosis
  3. Fatty Acid Synthase (FASN) Stearoyl-CoA Desaturase (SCD) Reactive Oxygen Species (ROS) Interleukin Related TNF Receptor SOD LDLR Glutathione Peroxidase
  4. FASN/SCD-IN-1

FASN/SCD-IN-1 is a Silybin (HY-N0779A) derivative, an orally active inhibitor of Fatty Acid Synthase (FASN)/Stearoyl-CoA Desaturase (SCD). FASN/SCD-IN-1 has shown in vitro activity in inhibiting lipid deposition, reducing FASN and SCD transcriptional levels, and exhibiting antioxidant, anti-inflammatory, and anti-fibrotic activities. FASN/SCD-IN-1 has demonstrated significant hepatoprotective effects in a rat model of acute liver injury. FASN/SCD-IN-1 ameliorates the pathological features of MASH liver, including steatosis, inflammation, and fibrosis in a mouse model of myeloproliferative steatohepatitis (MASH). FASN/SCD-IN-1 can be used to study MASH.

For research use only. We do not sell to patients.

FASN/SCD-IN-1

FASN/SCD-IN-1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

FASN/SCD-IN-1 Related Antibodies

Top Publications Citing Use of Products

View All Interleukin Related Isoform Specific Products:

View All Isoforms
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22

View All TNF Receptor Isoform Specific Products:

View All Isoforms
TNFRSF1A/CD120a TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

FASN/SCD-IN-1 is a Silybin (HY-N0779A) derivative, an orally active inhibitor of Fatty Acid Synthase (FASN)/Stearoyl-CoA Desaturase (SCD). FASN/SCD-IN-1 has shown in vitro activity in inhibiting lipid deposition, reducing FASN and SCD transcriptional levels, and exhibiting antioxidant, anti-inflammatory, and anti-fibrotic activities. FASN/SCD-IN-1 has demonstrated significant hepatoprotective effects in a rat model of acute liver injury. FASN/SCD-IN-1 ameliorates the pathological features of MASH liver, including steatosis, inflammation, and fibrosis in a mouse model of myeloproliferative steatohepatitis (MASH). FASN/SCD-IN-1 can be used to study MASH[1].

In Vitro

FASN/SCD-IN-1 (Compound A2) (100-200 μM, 20-30 min) shows scavenging ability for DPPH and O2•–, with scavenging rates of 92.9% and 82.9% respectively, with IC50s of 33.4, 28.1 μM, in terms of lipid peroxidation inhibition capacity (LPIC) assay, the inhibition rate of LPIC is 67.0%, with an IC50 of 41.7 μM[1].
FASN/SCD-IN-1 (10-40 μM, 24 h) reduces triglyceride (TG) levels and inhibits lipid accumulation in Palmitic acid (HY-N0830)/Oleic acid (HY-N1446) (PO)-stimulated LO2 cells and primary mouse hepatocytes, decreases fatty acid synthase (FASN) and stearoyl-CoA desaturase (SCD) transcript levels in PO-stimulated LO2 cells, decreases ACACA (encoding acetyl-CoA carboxylase) and FASN in PO-stimulated primary mouse hepatocytes[1].
FASN/SCD-IN-1 (1-10 μM, 24 h) reduces the excessive ROS and IL-6, TNF-α mRNA levels in Carbon tetrachloride CCl4 (HY-Y0298)-stimulated LO2 cells and primary mouse hepatocytes[1].
FASN/SCD-IN-1 (10-40 μM, 48 h) suppresses collagen I and fibronectin (FN) levels in TGF-β-stimulated LX2 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

FASN/SCD-IN-1 Related Antibodies

Western Blot AnalysisTGF-β-stimulated LX2 cells

Cell Line: TGF-β-stimulated LX2 cells
Concentration: 10 μM, 20 μM, 40 μM
Incubation Time: 48 h
Result: Suppressed collagen I and FN levels.
In Vivo

FASN/SCD-IN-1 (Compound A2) (100 mg/kg, i.g. once a day, 7 days) protects rats from acute liver injury by restoring hepatic function, reducing lipid accumulation, and ameliorating oxidative stress in CCl4-induced acute liver injury rat model[1].
FASN/SCD-IN-1 (150 mg/kg, p.o., once a day, 4 weeks) reduces steatosis, attenuates oxidative stress, inflammatory response, and liver fibrosis, and therefore markedly ameliorates the progression in HFD + CCl4-induced MASH mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: CCl4 (1 mg/kg, i.p.)-induced acute liver injury SD rat (male, 6 weeks) model[1]
Dosage: 100 mg/kg
Administration: i.g. once a day, 7 days
Result: Alleviated typical features of fatty liver disease, such as partial yellowing, darkening of the liver margins, white fat granules, and a rough surface.
Reduced the hepatopancreatic somatic index (HSI) and liver-to-body weight ratio.
Reduced serum AST, ALT, and LDH levels.
Reduced liver vacuoles, acute fat deposition, elevation of the MDA level and and restored SOD activity.
Animal Model: HFD + CCl4 (0.2 mg/kg, i.p., once a week)-induced MASH C57BL/6 mice (male, 6 weeks) model[1]
Dosage: 150 mg/kg
Administration: p.o., once a day, 4 weeks
Result: Protected body weight and counteracts CCl4 toxicity.
Reduced hepatopancreatic somatic index (HSI) and alleviates liver swelling.
Alleviated liver damage and reverses CCl4-induced liver enlargement, pale color, and mottled texture.
Reduced serum AST and ALT levels.
Improved liver structural distortion and reverses CCl4-induced hepatocellular ballooning, inflammation, and steatosis.
Ameliorated the dyslipidemia, reduced the elevated serum TG, cholesterol (CHO), and low-density lipoprotein cholesterol (LDL-c) levels and increased the lowered high-density lipoprotein cholesterol (HDL-c) levels.
Reduced the hepatic TG and CHO levels.
Restored the decreased liver GSH level and decrease the elevated MDA level, restore the decreased levels of both SOD and GSH-Px.
Reduced IL-6 and TNF-α levels, reduced collagen deposition, levels of α-SMA and collagen I in the liver tissue.
Molecular Weight

498.50

Formula

C25H22O9S
SMILES

OC1=C2C([C@@H]([C@H](OC2=CC(O)=C1)C3=CC4=C(C=C3)OC(CS)[C@H](C5=CC=C(C(OC)=C5)O)O4)O)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

FASN/SCD-IN-1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

FASN/SCD-IN-1Fatty Acid Synthase (FASN)Stearoyl-CoA Desaturase (SCD)Reactive Oxygen Species (ROS)Interleukin RelatedTNF ReceptorSODLDLRGlutathione PeroxidaseILTumor Necrosis Factor ReceptorTNFRSuperoxide DismutaseLow-density lipoprotein receptorInhibitorLO2 cellsprimary mouse hepatocytesLX2 cellsacute liver injurySD ratMASHinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
FASN/SCD-IN-1
Cat. No.:
HY-176274
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.